PPARG Gene Lipodystrophy Familial Partial Type 3 Genetic Test sale cost 4400 AED
CLDN16 Gene Hypomagnesemia Type 3 Genetic Test sale cost 4400 AED CLDN16 Gene Hypomagnesemia Type 3 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
BLK Gene Maturity-onset Diabetes of the Young Type 11 Genetic Test sale cost 4400 AED BLK Gene Maturity-onset Diabetes of the Young Type 11 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

PPARG Gene Lipodystrophy Familial Partial Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “PPARG Gene Lipodystrophy Familial Partial Type 3 Genetic Test” is a specialized diagnostic assessment conducted to identify mutations in the PPARG gene, which are associated with Familial Partial Lipodystrophy Type 3 (FPLD3). This condition is a rare genetic disorder characterized by the abnormal distribution of fat in the body, leading to a lack of fat in the arms and legs and excessive fat deposition in the central body. It can also predispose individuals to various metabolic complications such as diabetes, high cholesterol, and liver abnormalities.

Performed at DNA Labs UAE, this test is crucial for individuals with a family history of FPLD3 or those exhibiting symptoms suggestive of the condition. By analyzing the genetic makeup through a blood sample or cheek swab, the test aims to detect specific mutations in the PPARG gene that are indicative of the disorder. The outcome of this test not only aids in the accurate diagnosis of FPLD3 but also helps in the formulation of a personalized treatment plan to manage the symptoms and prevent the onset of related metabolic complications.

The cost of the PPARG Gene Lipodystrophy Familial Partial Type 3 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the analysis and the specialized technology employed, the test is priced to reflect the intricate processes involved in providing a definitive diagnosis. Individuals considering this test are encouraged to consult with a healthcare provider to understand its benefits, implications, and the next steps following the diagnosis.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PPARG Gene Lipodystrophy familial partial type 3 Genetic Test

At DNA Labs UAE, we offer the PPARG Gene Lipodystrophy familial partial type 3 Genetic Test. This test is designed to identify mutations or variations in the PPARG gene that may be responsible for the development of Lipodystrophy, familial partial, type 3 (FPLD3).

Test Details

The PPARG gene encodes a protein called peroxisome proliferator-activated receptor gamma (PPAR-gamma). This protein plays a crucial role in regulating genes involved in lipid metabolism and adipocyte differentiation. FPLD3 is a rare genetic disorder characterized by the loss of subcutaneous fat in specific areas of the body, such as the limbs, buttocks, and face. It can lead to metabolic abnormalities, including insulin resistance, dyslipidemia, and diabetes.

Components and Price

  • Test Name: PPARG Gene Lipodystrophy familial partial type 3 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the PPARG Gene Lipodystrophy familial partial type 3 Genetic Test, it is important for the patient to provide their clinical history. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with Lipodystrophy, familial partial, type 3. This information will help in the interpretation of the test results and provide appropriate recommendations.

Methodology

NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology used in the analysis of multiple genes simultaneously. In the case of genetic testing for FPLD3, NGS is employed to identify mutations or variations in the PPARG gene. By analyzing the patient’s DNA sample, NGS can detect specific changes in the PPARG gene sequence, such as single nucleotide variations (SNVs), insertions, deletions, or duplications.

Importance of Genetic Testing for FPLD3

Genetic testing for FPLD3 using NGS is crucial for diagnosing the condition and providing important information for genetic counseling, disease management, and potential treatment options. It is important to note that this test should be performed by a qualified geneticist or genetic counselor who can interpret the results and provide appropriate recommendations based on the individual’s specific case.

At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. If you suspect you or a family member may have Lipodystrophy, familial partial, type 3, we encourage you to consider our PPARG Gene Lipodystrophy familial partial type 3 Genetic Test. Contact us today to schedule an appointment or for more information.

Test Name PPARG Gene Lipodystrophy familial partial type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PPARG Gene Lipodystrophy, familial partial, type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Lipodystrophy, familial partial, type 3
Test Details

The PPARG gene is responsible for encoding a protein called peroxisome proliferator-activated receptor gamma (PPAR-gamma). This protein plays a crucial role in regulating the expression of genes involved in lipid metabolism and adipocyte differentiation.

Lipodystrophy, familial partial, type 3 (FPLD3) is a rare genetic disorder characterized by the loss of subcutaneous fat in specific areas of the body, such as the limbs, buttocks, and face. This condition can lead to metabolic abnormalities, including insulin resistance, dyslipidemia, and diabetes.

NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that can analyze multiple genes simultaneously. In the context of genetic testing for FPLD3, NGS can be used to identify mutations or variations in the PPARG gene that may be responsible for the development of the condition.

By analyzing the patient’s DNA sample, NGS can identify specific changes in the PPARG gene sequence, such as single nucleotide variations (SNVs), insertions, deletions, or duplications. These variations can help diagnose FPLD3 and provide important information for genetic counseling, disease management, and potential treatment options.

It’s important to note that genetic testing for FPLD3 using NGS should be performed by a qualified geneticist or genetic counselor who can interpret the results and provide appropriate recommendations based on the individual’s specific case.

SKU: TEST-2501 Category:

Related products